UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Direct transition to long-acting risperidone - analysis of long-term efficacy

Journal of psychopharmacology (Oxford), 2005-09, Vol.19 (5_suppl), p.15-21

2005

Volltextzugriff (PDF)

Preattentional processes and disorganization in schizophrenia: Influence of a 6-week risperidone treatment

Progress in neuro-psychopharmacology & biological psychiatry, 2009-10, Vol.33 (7), p.1107-1112

2009

Volltextzugriff (PDF)

Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone

Encéphale, 2008-04, Vol.34 (2), p.170-178

2008

Volltextzugriff (PDF)

Pharmacokinetic profile of long-acting injectable risperidone at steady-state : comparison with oral administration

Encéphale, 2005-09, Vol.31 (5), p.609-615

2005

Volltextzugriff (PDF)

Synthesis and evaluation of new arylbenzo[ b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus

Bioorganic & medicinal chemistry, 2007-07, Vol.15 (13), p.4482-4497

2007

Volltextzugriff (PDF)

Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers

Psychopharmacologia, 2003-02, Vol.165 (4), p.419-429

2003

Volltextzugriff (PDF)

C-2 Arylated benzo[b]thiophene Derivatives as staphylococcus aureus norA eflux pump inhibitors

ChemMedChem, 2016-02, Vol.11 (3), p.320-330

2016

Volltextzugriff (PDF)

Topiramate Pharmacokinetics in Children with Epilepsy Aged from 6 Months to 4 Years

Epilepsia (Copenhagen), 2004-11, Vol.45 (11), p.1448-1452

2004

Volltextzugriff (PDF)

Patient-based and clinician-based support for the remission criteria in schizophrenia

International clinical psychopharmacology, 2007-01, Vol.22 (1), p.51

2007

Volltextzugriff (PDF)

Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers

British journal of clinical pharmacology, 2001-02, Vol.51 (2), p.164-168

2001

Volltextzugriff (PDF)

Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients

Journal of clinical psychopharmacology, 1996-02, Vol.16 (1), p.38-44

1996

Volltextzugriff (PDF)

Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers

Clinical neurophysiology, 2002-03, Vol.113 (3), p.429-434

2002

Volltextzugriff (PDF)

P.3.a.048 Insight in schizophrenia: clinical correlates and relationship to functioning

European neuropsychopharmacology, 2006, Vol.16, p.S390-S391

2006

Volltextzugriff (PDF)

P.2.a.007 “Difficult depression” at private psychiatric clinics throughout France: an epidemiological survey (DEDICACE survey)

European neuropsychopharmacology, 2006, Vol.16, p.S286-S287

2006

Volltextzugriff (PDF)

Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses

International clinical psychopharmacology, 1992-11, Vol.7 (2), p.73-80

1992

Volltextzugriff (PDF)

P.3.a.013 Untreated patients with schizophrenia have a failure of inhibitory control systems during saccadic tasks

European neuropsychopharmacology, 2006, Vol.16, p.S371-S371

2006

Volltextzugriff (PDF)

P.3.c.015 Pre-attentive processes and attention: effect of risperidone for 6 weeks in untreated patients with schizophrenia and correlation with disorganization

European neuropsychopharmacology, 2006, Vol.16, p.S404-S405

2006

Volltextzugriff (PDF)

Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus

European journal of medicinal chemistry, 2007 (15), p.4482-4497

2007

Volltextzugriff (PDF)

Direct transition to long-acting risperidone : analysis of long-term efficacy: Progress in modern psychopharmacology: clinical experience with risperidone long-acting injectable in Schizophrenia and Schizoaffective disorders

Journal of psychopharmacology (Oxford), 2005, Vol.19 (5), p.15-21

2005

Volltextzugriff (PDF)

Memoire, attention, potentiels evoques au cours du vieillissement et dans la demence senile de type Alzheimer

Neurophysiologie clinique, 1988-04, Vol.18 (2), p.153-160

1988

Volltextzugriff (PDF)

A survey on the position of France in international clinical research as assessed by pharmaceutical laboratories

Therapie, 2004-11, Vol.59 (6), p.629

2004

Volltextzugriff (PDF)

Memory, attention and evoked potentials during aging and in Alzheimer type senile dementia

Neurophysiologie clinique, 1988-04, Vol.18 (2), p.153-160

1988

Volltextzugriff (PDF)

Memory, attention and evoked potentials during aging and in Alzheimer type senile dementia

Neurophysiologie clinique, 1988-04, Vol.18 (2), p.153

1988

Volltextzugriff (PDF)

Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses

International clinical psychopharmacology, 1992-11, Vol.7 (2), p.73-80

1992

Volltextzugriff (PDF)

Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophrenia

Progress in neuro-psychopharmacology & biological psychiatry, 1994-03, Vol.18 (2), p.347-353

1994

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(66)
Französisch
(41)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Direct transition to long-acting risperidone - analysis of long-term efficacy

Preattentional processes and disorganization in schizophrenia: Influence of a 6-week risperidone treatment

Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone

Pharmacokinetic profile of long-acting injectable risperidone at steady-state : comparison with oral administration

Synthesis and evaluation of new arylbenzo[ b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus

Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers

C-2 Arylated benzo[b]thiophene Derivatives as staphylococcus aureus norA eflux pump inhibitors

Topiramate Pharmacokinetics in Children with Epilepsy Aged from 6 Months to 4 Years

Patient-based and clinician-based support for the remission criteria in schizophrenia

Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers

Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients

Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers

P.3.a.048 Insight in schizophrenia: clinical correlates and relationship to functioning

P.2.a.007 “Difficult depression” at private psychiatric clinics throughout France: an epidemiological survey (DEDICACE survey)

Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses

P.3.a.013 Untreated patients with schizophrenia have a failure of inhibitory control systems during saccadic tasks

P.3.c.015 Pre-attentive processes and attention: effect of risperidone for 6 weeks in untreated patients with schizophrenia and correlation with disorganization

Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus

Direct transition to long-acting risperidone : analysis of long-term efficacy: Progress in modern psychopharmacology: clinical experience with risperidone long-acting injectable in Schizophrenia and Schizoaffective disorders

Memoire, attention, potentiels evoques au cours du vieillissement et dans la demence senile de type Alzheimer

A survey on the position of France in international clinical research as assessed by pharmaceutical laboratories

Memory, attention and evoked potentials during aging and in Alzheimer type senile dementia

Memory, attention and evoked potentials during aging and in Alzheimer type senile dementia

Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses

Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophrenia

Suchergebnisse filtern